Document quand l'auteur est "Mousavifar, Leila"Aller à Article Nombre de documents archivés : 6. ArticleLewicky, Jordan D.; Martel, Alexandrine L.; Fraleigh, Nya L.; Picard, Emilie; Mousavifar, Leila; Nakamura, Arnaldo; Diaz-Mitoma, Francisco; Roy, René et Le, Hoang-Thanh (2022). Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy Pharmaceutics , vol. 14 , nº 12:2710. pp. 1-21. DOI: 10.3390/pharmaceutics14122710.
Mousavifar, Leila; Lewicky, Jordan D.; Taponard, Alexis; Bagul, Rahul; Rivat, Madleen; Abdullayev, Shuay; Martel, Alexandrine L.; Fraleigh, Nya L.; Nakamura, Arnaldo; Veyrier, Frédéric Mousavifar, Leila et Roy, René (2021). Recent development in the design of small 'drug-like' and nanoscale glycomimetics against Escherichia coli infections Drug Discovery Today , vol. 26 , nº 9. pp. 2124-2137. DOI: 10.1016/j.drudis.2021.02.025. Mousavifar, Leila; Vergoten, Gérard; Charron, Guillaume et Roy, René (2019). Comparative Study of Aryl O-, C-, and S-Mannopyranosides as Potential Adhesion Inhibitors toward Uropathogenic E. coli FimH Molecules , vol. 24 , nº 3566. pp. 1-12. DOI: 10.3390/molecules24193566. Mousavifar, Leila; Vergoten, Gérard et Roy, René (2018). Deciphering the conformation of C-linked α-D-mannopyranosides and their application toward the synthesis of low nanomolar E. Coli FimH ligands ARKIVOC: Free Online Journal of Organic Chemistry , vol. 2018 , nº 7. pp. 384-397. DOI: 10.24820/ark.5550190.p010.783. Mousavifar, Leila; Touaibia, Mohamed et Roy, René (2018). Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections Accounts of Chemical Research , vol. 51 , nº 11. pp. 2937-2948. DOI: 10.1021/acs.accounts.8b00397. |